The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

Mar. 07, 2018
Applicant:

Nantcell, Inc., Culver City, CA (US);

Inventors:

Patrick Soon-Shiong, Culver City, CA (US);

Shahrooz Rabizadeh, Culver City, CA (US);

Kayvan Niazi, Culver City, CA (US);

Stephen Charles Benz, Culver City, CA (US);

Laurent H. Boissel, Culver City, CA (US);

Hans Klingemann, Culver City, CA (US);

Barry J. Simon, Culver City, CA (US);

Assignee:

NantCell, Inc., Culver City, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); G01N 33/50 (2006.01); G16H 50/30 (2018.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
G01N 33/5047 (2013.01); C12N 5/0646 (2013.01); C12Q 1/6886 (2013.01); G16H 50/30 (2018.01); C12Q 2600/158 (2013.01); G01N 2800/7014 (2013.01); G01N 2800/7038 (2013.01);
Abstract

Detection of under-expression of selected genes in NK cells is used to confirm a hypoxic tumor microenvironment that is ordinarily suppressive with respect to ADCC and cytotoxic cell killing of NK cells. Most notably, while hypoxia is known to upregulate HIF-1α and genes under the control of HIF-1α, hypoxia in a tumor microenvironment led to under-expression of selected genes, including HIF-1α. Thus, gene expression analysis of certain genes on NK cells can be used to detect conditions in a tumor that would indicate use of haNK cells.


Find Patent Forward Citations

Loading…